Both in Biotechnology
Scribe Therapeutics vs X4 Pharmaceuticals
Over the past year SCTX returned −48.2% and XFOR returned −4.3%; their daily moves had a correlation of 0.18.
SCTX −48.2% XFOR −4.3%Growth of $1, one year, split-adjusted
| Metric | SCTX | XFOR |
|---|---|---|
| Price | $15.42 | $3.35 |
| Market cap | $291.9M | $332.1M |
| Today | −11.58% | −0.30% |
| 1 month | −10.2% | +18.4% |
| 6 months | — | −20.0% |
| Year to date | — | −16.3% |
| 1 year | — | −10.4% |
| Revenue growth (YoY) | — | +346.3% |
| Gross margin | — | 81.6% |
| Net margin | — | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 21.0× |
| Net cash | — | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 66.2% |
| Short % of float | 14.6% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).